{
    "title": "AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12020669/AbbVie-misses-sales-estimates-drugs-shares-tumble.html",
    "date": "2023-04-27",
    "keywords": [
        "quarter",
        "company",
        "abbvie",
        "revenue",
        "competition",
        "humira",
        "leo",
        "inc",
        "drug",
        "profit",
        "rinvoq",
        "amgen",
        "wingrove",
        "thursday",
        "blow",
        "flagship",
        "forecast",
        "decline",
        "performance",
        "skyrizi",
        "estimate",
        "arthritis",
        "treatment",
        "market",
        "erosion",
        "year",
        "biosimilar",
        "discount",
        "price",
        "morning",
        "trading",
        "cliff",
        "loss",
        "exclusivity",
        "acquisition",
        "allergan",
        "cash",
        "cow",
        "botox",
        "psoriasis",
        "autoimmune",
        "product",
        "confidence",
        "growth",
        "inflammation",
        "franchise",
        "softness",
        "isnt",
        "trend",
        "capital",
        "analyst",
        "seigerman",
        "street",
        "use",
        "share",
        "range",
        "month",
        "hit",
        "inprocess",
        "research",
        "development",
        "milestone",
        "mariam",
        "e",
        "sunny",
        "bengaluru",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}